Rosuvastatin ameliorates metabolic dyslipidemia and insulin resistance in an animal model of the metabolic syndrome

被引：0
|
作者：
Naples, M [1 ]
Federico, L [1 ]
Taylor, D [1 ]
Adeli, K [1 ]
机构：
[1] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2006年 / 26卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E82 / E82
页数：1
相关论文
共 50 条
  • [21] KS is a model for childhood insulin resistance and metabolic syndrome
    Zeger, Martha P.
    Ross, Judith L.
    HORMONE RESEARCH, 2009, 72 : 335 - 335
  • [22] Rosuvastatin therapy for dyslipidemia and other associated parameters in Saudi metabolic syndrome patients
    Rafeeq, Misbahuddin
    Habib, Hamed
    Murad, Hussam
    Gari, Mamdouh
    Gazzaz, Zohair
    FASEB JOURNAL, 2017, 31
  • [23] Effect of rosuvastatin on dyslipidemia and other parameters associated with metabolic syndrome in Saudi patients
    Rafeeq, M. M.
    Habib, H. S.
    Murad, H. A. S.
    Gari, M. A.
    Gazzaz, Z. J.
    NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2017, 20 (04) : 445 - 453
  • [24] Dyslipidemia and the metabolic syndrome
    Bloomgarden, ZT
    DIABETES CARE, 2004, 27 (12) : 3009 - 3016
  • [25] Dyslipidemia and metabolic syndrome
    Fuehrer, Dagmar
    Reincke, Martin
    INNERE MEDIZIN, 2023, 64 (07): : 609 - 610
  • [26] Dyslipidemia of the metabolic syndrome
    Ruotolo G.
    Howard B.V.
    Current Cardiology Reports, 2002, 4 (6) : 494 - 500
  • [27] Comparison of SGLT inhibitors in an animal model of metabolic syndrome: effect on metabolic parameters and insulin sensitivity
    Trnovska, J.
    Huttl, M.
    Markova, I.
    Oliyarnyk, O.
    Malinska, H.
    Miklankova, D.
    Kratochvilova, H.
    Svoboda, P.
    Lankova, I.
    Mraz, M.
    Haluzik, M.
    DIABETOLOGIA, 2019, 62 : S235 - S235
  • [28] The metabolic syndrome - Beyond the insulin resistance syndrome
    Penno, Giuseppe
    Miccoli, Roberto
    Pucci, Laura
    Del Prato, Stefano
    PHARMACOLOGICAL RESEARCH, 2006, 53 (06) : 457 - 468
  • [29] Improvement bioavailability of silymarin ameliorates severe dyslipidemia associated with metabolic syndrome
    Poruba, Martin
    Kazdova, Ludmila
    Oliyarnyk, Olena
    Malinska, Hana
    Matuskova, Zuzana
    di Angelo, Igor Tozzi
    Skop, Vojtech
    Vecera, Rostislav
    XENOBIOTICA, 2015, 45 (09) : 751 - 756
  • [30] Association of insulin resistance with the metabolic syndrome
    Chiu, K
    Chu, A
    Saad, M
    DIABETES, 2003, 52 : A496 - A496
12345